PRODUCTS & INNOVATION
Our key products helped deliver impressive growth, exceeding expectations and jump-starting another strong year.
Apr 17 2019
We just closed the books on the first quarter of 2019 and our key products are helping to deliver another strong start for Abbott.
For the quarter, we delivered sales growth of more than 7% (on an organic basis) and exceeded our previous ongoing earnings-per-share guidance thanks to key products such as FreeStyle Libre, Alinity and MitraClip. We are also seeing several other bright spots throughout our portfolio in our medical devices, nutrition and established pharma businesses.
And, our innovative pipeline and focused execution is continuing to pay off. We saw more than 10 significant product approvals and developments in the first quarter alone.
Some of the highlights include:
For full financials, you can read our press release, or take a look at some additional materials below:
Abbott's Chairman and CEO Miles D. White shared his views on first-quarter performance:
Learn more about Abbott's first-quarter 2019 results:
Download a summary of Abbott's earnings highlights here.
For more information on Abbott's earnings results, see the news release.
*Alinity m is in development and not commercially available in the United States for diagnostic use.
Abbott Reports 2Q Results, Ups Guidance
More Relevant Than Ever for Our Health
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.